Saudi Arabia Ophthalmic Devices Market Size and Share

Saudi Arabia Ophthalmic Devices Market (2025 - 2030)
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
View Global Report

Saudi Arabia Ophthalmic Devices Market Analysis by Mordor Intelligence

The Saudi Arabia ophthalmic devices market size is valued at USD 0.58 billion in 2025 and is forecast to reach USD 0.77 billion by 2030, registering a 5.76% CAGR. This advance is anchored in Vision 2030’s USD 65 billion healthcare-modernization plan. Sustained demand arises from a diabetes burden that climbed to 7 million cases in 2021 and is expected to hit 8.4 million by 2030, heightening the need for screening and monitoring technologies. Rapid adoption of artificial-intelligence (AI) diagnostics, growing private investment in ambulatory eye-care centers, and the emergence of Riyadh and Jeddah as medical-tourism hubs further energize the Saudi Arabia ophthalmic devices market. Headwinds persist, however, in the form of import dependency that raises device prices and a shortage of certified technicians, which limits throughput despite equipment availability. Policymakers are therefore refining Saudi Food and Drug Authority (SFDA) procedures and funding training pipelines to ease these constraints.

Key Report Takeaways

  • By device type, vision care devices held 60.41% of the Saudi Arabia ophthalmic devices market share in 2024; Diagnostic & monitoring devices are projected to expand at a 7.86% CAGR through 2030.
  • By disease indication, cataract accounted for 35.61% of the Saudi Arabia ophthalmic devices market size in 2024, while Diabetic retinopathy is set to grow at a 7.04% CAGR to 2030.
  • By end-user, hospitals commanded 45.71% revenue share in 2024; Ambulatory surgery centers are expected to post a 6.92% CAGR during 2025-2030.

Segment Analysis

By Device Type: Diagnostic Equipment Accelerates Innovation

Vision care devices retained a 60.41% share of the Saudi Arabia ophthalmic devices market in 2024, supported by steady demand for spectacles, contact lenses, and dispensing systems. Diagnostic & Monitoring Devices, however, are set to expand at a 7.86% CAGR through 2030, reflecting hospitals’ shift toward early-stage disease identification. Within this cluster, optical-coherence-tomography scanners should command 24.42% of diagnostic revenue in 2024, benefiting from superior retinal-layer visualisation that aids macular-degeneration and diabetic-retinopathy screening. Ultra-wide-field fundus cameras also post strong orders because clinicians want comprehensive peripheral-retina images to detect lesions missed by 45-degree systems.

The diagnostic up-cycle is reinforced by national tele-health mandates that integrate cloud-based image management and AI grading. As a result, the Saudi Arabia ophthalmic devices market size allocated to diagnostic hardware rises in tandem with digitally linked screening programmes. Surgical-device demand grows at a moderate clip, buoyed by premium intra-ocular-lens adoption in elective cataract and refractive procedures popular in Riyadh and Jeddah. Import tariffs remain a drag on smaller buyers, but multinational suppliers offset duties with leasing options and bundled-service contracts.

Saudi Arabia Ophthalmic Devices Market: Market Share by Device Type
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Disease Indication: Diabetic Retinopathy Drives Digital Transformation

Cataract retained 35.61% of revenue in 2024, reflecting an ageing population and high surgery volumes in public hospitals. Diabetic retinopathy now registers the fastest growth trajectory with a 7.04% CAGR forecast for 2025-2030, propelled by a diabetes prevalence that reached 7 million patients in 2021. The Saudi Arabia ophthalmic devices market size tied to diabetic-retinopathy care is therefore climbing quickly as payers subsidise AI-based fundus-camera networks and OCT-angiography units for microvascular mapping.

Glaucoma follows with innovation in micro-invasive implants that lower intra-ocular pressure while reducing recovery time. Cataract solutions continue to benefit from premium multifocal- and toric-lens demand among self-pay and medical-tourism cases. Vendors are introducing disposable vitrectomy packs and dual-platform phaco systems to optimise operating-room turnover in high-volume centres, sustaining overall sales momentum despite price pressures.

Saudi Arabia Ophthalmic Devices Market: Market Share by Disease Indication
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By End-User: Ambulatory Surgery Centers Capture Outpatient Shift

Hospitals captured 45.71% of total expenditure in 2024, leveraging integrated care pathways and capital-budget cycles. Yet Ambulatory Surgery Centers (ASCs) are slated for a 6.92% CAGR, mirroring a global pivot toward day-case ophthalmology, especially cataract and LASIK procedures. Government incentives that lift private-sector participation to 68% by 2030 encourage investors to build ASC networks equipped with femtosecond lasers, phaco platforms, and point-of-care diagnostics—all sourced from the Saudi Arabia ophthalmic devices market.

Specialty ophthalmic clinics also scale quickly as regional chains expand footprints beyond Tier-1 cities. These clinics concentrate on refractive and retina-care niches, purchasing compact imaging towers and portable lasers to fit smaller surgical suites. Hospitals still dominate complex ocular-oncology, paediatric, and trauma cases, ensuring baseline demand for high-acuity microscopes and vitrectomy consoles.

Competitive Landscape

The Saudi Arabia ophthalmic devices market features a moderate concentration. Global OEMs such as Alcon, Carl Zeiss Meditec, Johnson & Johnson Vision, and Bausch + Lomb dominate high-tech segments, leveraging broad portfolios and service networks. Alcon’s Experience Center in Jeddah provides surgeon training and on-site demonstrations, consolidating its influence over premium-device procurement. Multinationals hold a strong foothold in diagnostic imaging and surgical disposables, sectors requiring capital intensity and regulatory experience.

Local and regional chains, including Magrabi Health and Saudi German Hospital Group, compete on service breadth and geographic coverage, often partnering with global suppliers for technology transfers and joint-training initiatives. The rise of AI-based tele-retinopathy platforms creates space for software-driven entrants that differentiate through algorithm accuracy rather than hardware pedigree. Import duties and SFDA timelines, however, favor established distributors that can navigate compliance and finance inventory.

White-space opportunities exist in mobile screening units, low-cost portable fundus cameras, and technician training services. International start-ups offering handheld OCT and smartphone-based anterior-segment imaging may gain traction if they secure authorized-representative partnerships and local technical support. Price-sensitive public tenders still consider value over premium features, positioning mid-tier vendors for share gains once SABER procedures stabilize.

Saudi Arabia Ophthalmic Devices Industry Leaders

  1. Alcon Inc

  2. Bausch Health Companies Inc

  3. Carl Zeiss Meditec AG

  4. Johnson & Johnson Vision Care

  5. EssilorLuxottica SA

  6. *Disclaimer: Major Players sorted in no particular order
Saudi Arabia Ophthalmic Devices Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • April 2025: The World Council of Optometry chose Riyadh to host the 6th World Congress of Optometry in 2026, emphasizing education and research collaboration.
  • March 2025: Alcon inaugurated its first Alcon Experience Center in Jeddah, signing training pacts with four leading hospitals to deepen surgical-skill development.
  • February 2025: Almoosa Health reported FY 2024 revenue growth of 22.8% to SAR 1,202.3 million and announced plans to double bed capacity by 2028 in line with Vision 2030 goals.
  • November 2024: The SFDA released MDS G002 version 3.0, refining pathways for innovative medical-device approvals, including ophthalmic equipment.
  • January 2024: SASO adopted new product-safety regulations applicable to ophthalmic devices, strengthening quality-control enforcement.

Table of Contents for Saudi Arabia Ophthalmic Devices Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Government-Funded Vision 2030 Ophthalmology Infrastructure Expansion
    • 4.2.2 High Diabetes Prevalence Driving AI-Based Diabetic-Retinopathy Screening Uptake
    • 4.2.3 Compulsory Pre-Marital & School Eye-Health Screening Programmes
    • 4.2.4 Rise of Premium Elective LASIK & Cataract Surgeries Via Medical-Tourism Hubs (Riyadh, Jeddah)
    • 4.2.5 Emergence of Public-Private Ophthalmic Centres of Excellence Under NHC PPP Model
    • 4.2.6 Rapid Adoption of Cloud-Connected OCT & Fundus Cameras in Primary-Care Polyclinics
  • 4.3 Market Restraints
    • 4.3.1 Import-Dependence Inflating Device Prices Post-Tariff Harmonisation (SFDA)
    • 4.3.2 Shortage of Certified Ophthalmic Technicians Limiting Diagnostic Throughput
    • 4.3.3 Lengthy SFDA Device-Registration Timelines Delaying Launches
    • 4.3.4 Price-Sensitive Contact-Lens E-Commerce Dampening Uptake of Premium Vision-Care Devices
  • 4.4 Regulatory Outlook
  • 4.5 Porter's Five Forces Analysis
    • 4.5.1 Threat of New Entrants
    • 4.5.2 Bargaining Power of Buyers
    • 4.5.3 Bargaining Power of Suppliers
    • 4.5.4 Threat of Substitutes
    • 4.5.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Device Type
    • 5.1.1 Diagnostic & Monitoring Devices
    • 5.1.1.1 OCT Scanners
    • 5.1.1.2 Fundus & Retinal Cameras
    • 5.1.1.3 Autorefractors & Keratometers
    • 5.1.1.4 Corneal Topography Systems
    • 5.1.1.5 Ultrasound Imaging Systems
    • 5.1.1.6 Perimeters & Tonometers
    • 5.1.1.7 Other Diagnostic & Monitoring Devices
    • 5.1.2 Surgical Devices
    • 5.1.2.1 Cataract Surgical Devices
    • 5.1.2.2 Vitreoretinal Surgical Devices
    • 5.1.2.3 Refreactive Surgical Devices
    • 5.1.2.4 Glaucoma Surgical Devices
    • 5.1.2.5 Other Surgical Devices
    • 5.1.3 Vision Care Devices
    • 5.1.3.1 Spectacles Frames & Lenses
    • 5.1.3.2 Contact Lenses
  • 5.2 By Disease Indication
    • 5.2.1 Cataract
    • 5.2.2 Glaucoma
    • 5.2.3 Diabetic Retinopathy
    • 5.2.4 Other Disease Indications
  • 5.3 By End-user
    • 5.3.1 Hospitals
    • 5.3.2 Specialty Ophthalmic Clinics
    • 5.3.3 Ambulatory Surgery Centers (ASCs)
    • 5.3.4 Other End-users

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
    • 6.3.1 Alcon Inc
    • 6.3.2 Bausch Health Companies Inc
    • 6.3.3 Carl Zeiss Meditec AG
    • 6.3.4 Johnson & Johnson Vision Care
    • 6.3.5 EssilorLuxottica SA
    • 6.3.6 NIDEK Co Ltd
    • 6.3.7 Topcon Corp
    • 6.3.8 HAAG-Streit Group
    • 6.3.9 Glaukos Corp
    • 6.3.10 CooperVision Inc
    • 6.3.11 STAAR Surgical
    • 6.3.12 Lumibird Medical
    • 6.3.13 Oculus Optikgerte GmbH
    • 6.3.14 Reichert Technologies
    • 6.3.15 BVI Medical

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Saudi Arabia Ophthalmic Devices Market Report Scope

As per the scope of the report, ophthalmology is a branch of medical science that deals with structure, function, and various diseases related to the eye. Ophthalmic devices are medical equipment designed for diagnosis, surgical, and vision correction purposes. The Saudi Arabia Ophthalmic Devices Market is segmented by Device (Surgical Devices, Diagnostic and Monitoring Devices, and Vision Correction Devices). The report offers the value (in USD million) for the above segments.

By Device Type
Diagnostic & Monitoring Devices OCT Scanners
Fundus & Retinal Cameras
Autorefractors & Keratometers
Corneal Topography Systems
Ultrasound Imaging Systems
Perimeters & Tonometers
Other Diagnostic & Monitoring Devices
Surgical Devices Cataract Surgical Devices
Vitreoretinal Surgical Devices
Refreactive Surgical Devices
Glaucoma Surgical Devices
Other Surgical Devices
Vision Care Devices Spectacles Frames & Lenses
Contact Lenses
By Disease Indication
Cataract
Glaucoma
Diabetic Retinopathy
Other Disease Indications
By End-user
Hospitals
Specialty Ophthalmic Clinics
Ambulatory Surgery Centers (ASCs)
Other End-users
By Device Type Diagnostic & Monitoring Devices OCT Scanners
Fundus & Retinal Cameras
Autorefractors & Keratometers
Corneal Topography Systems
Ultrasound Imaging Systems
Perimeters & Tonometers
Other Diagnostic & Monitoring Devices
Surgical Devices Cataract Surgical Devices
Vitreoretinal Surgical Devices
Refreactive Surgical Devices
Glaucoma Surgical Devices
Other Surgical Devices
Vision Care Devices Spectacles Frames & Lenses
Contact Lenses
By Disease Indication Cataract
Glaucoma
Diabetic Retinopathy
Other Disease Indications
By End-user Hospitals
Specialty Ophthalmic Clinics
Ambulatory Surgery Centers (ASCs)
Other End-users
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current value of the Saudi Arabia ophthalmic devices market?

The market is valued at USD 0.58 billion in 2025 and is projected to rise to USD 0.77 billion by 2030.

Which device category is expanding the fastest?

Diagnostic & Monitoring Devices are forecast to grow at a 7.86% CAGR between 2025 and 2030, driven by AI-enabled imaging adoption.

How significant is diabetic retinopathy in driving demand?

Diabetic retinopathy affects 31% of diabetics, spurring rapid uptake of AI-based screening and making it the fastest-growing disease segment at a 7.04% CAGR.

Why are Ambulatory Surgery Centers gaining traction?

ASCs benefit from cost efficiencies and Vision 2030’s privatization push, resulting in an expected 6.9% CAGR through 2030 for ophthalmic procedures.

What regulations influence import pricing?

SFDA registration, ISO 13485 compliance, and the SABER platform add to import costs, increasing prices by around 15% for high-end devices.

Where are premium elective surgeries concentrated?

Riyadh and Jeddah host most premium LASIK and cataract procedures, supported by centers such as Magrabi Health and new facilities like Alcon’s Experience Center.

Page last updated on:

Saudi Arabia Ophthalmic Devices Report Snapshots